High Dose Intravenous Busulfan and Melphalan Followed By Bortezomib (BuMelVel) As Conditioning With Autologous Stem Cell Transplantation (ASCT) For Patients With Multiple Myeloma (MM)

被引：0
|
作者：
Sterrenberg, Danielle
Stiff, Patrick J.
Parthasarathy, Mala
Go, Aileen
Smith, Scott E.
Rodriguez, Tulio E.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3376.3376
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3376
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM
    Saini, Neeraj
    Bashir, Qaiser
    Milton, Denai R.
    Tang, Guilin
    Delgado, Ruby
    Rondon, Gabriela
    Popat, Uday R.
    Hosing, Chitra M.
    Nieto, Yago
    Kebriaei, Partow
    Alousi, Amin M.
    Mehta, Rohtesh
    Srour, Samer
    Khouri, Issa F.
    Weber, Donna M.
    Thomas, Sheeba K.
    Lee, Hans C.
    Patel, Krina K.
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BLOOD ADVANCES, 2020, 4 (19) : 4834 - 4837
  • [32] High-dose melphalan followed by two doses of bortezomib as conditioning regimen for the patients with multiple myeloma may increase response rate after autologous stem cell transplantation
    Liu, K-Y.
    Chen, H.
    Jiang, B.
    Wang, Y.
    Zhu, H. -H.
    Sun, Y. -Q.
    Lu, J.
    Bao, L.
    Huang, X. -J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S188 - S188
  • [33] Bortezomib and Melphalan (Bor/MEL) Conditioning for Patients with Multiple Myeloma Undergoing Single Autologous Stem Cell Transplantation
    Zepeda, Victor H. Jimenez
    Duggan, Peter
    Neri, Paola E.
    Bahlis, Nizar J.
    BLOOD, 2014, 124 (21)
  • [34] Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma
    Hagen, Patrick
    Norton, Joseph
    Tsai, Stephanie
    Campo, Loredana
    Lee, Mary
    Gomez, Kayeromi
    Stiff, Patrick
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1422 - 1428
  • [35] Intravenous busulfan and melphalan as conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-based approach
    Blanes, M.
    Lahuerta, J. J.
    Gonzalez, J. D.
    Ribas, P.
    Solano, C.
    Alegre, A.
    Blade, J.
    San Miguel, J. F.
    Sanz, M. A.
    de la Rubia, J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S330 - S331
  • [36] Matched pair analysis of intravenous busulfan and melphalan vs. melphalan alone as conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation
    de la Rubia, J.
    Lahuerta, J. J.
    Gonzalez, J. D.
    Ribas, P.
    Solano, C.
    Blade, J.
    San Miguel, J. F.
    Sanz, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 192 - 192
  • [37] Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma
    Barta, Stefan K.
    Jain, Rishi
    Mazumder, Amithaba
    Carter, Jason
    Almanzar, Lawrence
    Browne, Roy
    Shahnaz, Samira
    Elkind, Richard
    Kaminetzky, David
    Battini, Ramakrishna
    Derman, Olga
    Kornblum, Noah
    Verma, Amit
    Braunschweig, Ira
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10) : 650 - 657
  • [38] Routine care of patients with Multiple Myeloma (MM) 01/2019-12/2020 not suitable for high-dose melphalan therapy followed by autologous stem cell transplantation (ASCT)
    Weide, R.
    Mohm, J.
    Klausmann, M.
    Linde, H.
    Rothe, A.
    Steinmetz, T.
    Hensel, M.
    Ehscheidt, P.
    Reiser, M.
    Doerfel, S.
    Mueller, L.
    Schmidt, B.
    Maasberg, M.
    Burkhard, O.
    Feiten, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 181 - 182
  • [39] PK-Directed Intravenous Busulfan In Combination With High-Dose Melphalan and Bortezomib As Conditioning Regimen For Patients With Multiple Myeloma
    Barta, Stefan K.
    Mazumder, Amitabha
    Carter, Jason
    Almanzar, Lawrence
    Elkind, Richard
    Battini, Ramakrishna
    Derman, Olga
    Kornblum, Noah
    Xue, Xiaonan
    Verma, Amit
    Braunschweig, Ira
    BLOOD, 2013, 122 (21)
  • [40] PK-Directed Intravenous Busulfan in Combination with High-Dose Melphalan and Bortezomib As Conditioning Regimen for Patients with Multiple Myeloma
    Barta, Stefan Klaus
    Mazumder, Amitabha
    Carter, Jason
    Almanzar, Lawrence
    Elkind, Richard
    Battini, Ramakrishna
    Derman, Olga
    Kornblum, Noah
    Xue, Xionan
    Verma, Amit
    Braunschweig, Ira
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S104 - S105
12345